SALIX PHARMACEUTICALS LTD Patent Applications Rejected
7 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2018-11-30: Application 16206570; Invention METHODS FOR TREATMENT AND PREVENTION OF OPIOID INDUCED CONSTIPATION USING ORAL COMPOSITIONS OF METHYLNALTREXONE; Applicant Salix Pharmaceuticals, Ltd.; Status Abandoned -- Failure to Respond to an Office Action.
- 2017-06-06: Application 15615121; Invention FORMULATIONS OF RIFAXIMIN AND USES THEREOF; Applicant Salix Pharmaceuticals, Ltd; Status Abandoned -- Failure to Respond to an Office Action.
- 2016-09-30: Application 15281543; Invention FORMULATIONS OF RIFAXIMIN AND USES THEREOF; Applicant Salix Pharmaceuticals, Ltd; Status Abandoned -- After Examiner's Answer or Board of Appeals Decision.
- 2015-11-05: Application 14933253; Invention METHODS OF USING RIFAXIMIN IN POSITION EMISSION TOMOGRAPHY (PET) SCANS; Applicant Salix Pharmaceuticals, Ltd; Status Abandoned -- Failure to Respond to an Office Action.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2018-11-30 | 16206570 | METHODS FOR TREATMENT AND PREVENTION OF OPIOID INDUCED CONSTIPATION USING ORAL COMPOSITIONS OF METHYLNALTREXONE | Salix Pharmaceuticals, Ltd. | Abandoned -- Failure to Respond to an Office Action | US20190231771A1 | Enoch Bortey | United States | DRAPER, LESLIE A ROYDS |
| 2017-06-06 | 15615121 | FORMULATIONS OF RIFAXIMIN AND USES THEREOF | Salix Pharmaceuticals, Ltd | Abandoned -- Failure to Respond to an Office Action | US20170333562A1 | Jon Selbo Jing Teng Mohammed A. Kabir Pam Golden | United States United States United States United States | KASSA, TIGABU |
| 2016-09-30 | 15281543 | FORMULATIONS OF RIFAXIMIN AND USES THEREOF | Salix Pharmaceuticals, Ltd | Abandoned -- After Examiner's Answer or Board of Appeals Decision | US20170087134A1 | Pam Golden Mohammed A. Kabir | United States United States | KASSA, TIGABU |
| 2015-11-05 | 14933253 | METHODS OF USING RIFAXIMIN IN POSITION EMISSION TOMOGRAPHY (PET) SCANS | Salix Pharmaceuticals, Ltd | Abandoned -- Failure to Respond to an Office Action | US20160128990A1 | Alan C. Moss | United States | GRAZIER, NYEEMAH A |
| 2015-02-24 | 14629871 | METHODS OF IMPROVING LONG-TERM SURVIVAL AND REDUCING HOSPITALIZATION READMISSION RATES FOR SUBJECTS SUFFERING FROM HEPATIC ENCEPHALOPATHY | Salix Pharmaceuticals, Ltd | Abandoned -- Failure to Respond to an Office Action | US20150164867A1 | Guy Neff | United States | HAVLIN, ROBERT H |
| 2015-02-24 | 14629869 | METHODS OF ADMINISTERING RIFAXIMIN FOR WEIGHT LOSS AND TREATMENT OF OBESITY | Salix Pharmaceuticals, Ltd | Abandoned -- Failure to Respond to an Office Action | US20150164866A1 | Charles W. Randall | United States | HAVLIN, ROBERT H |
| 2012-12-19 | 13720235 | METHODS FOR TREATMENT AND PREVENTION OF OPIOID INDUCED CONSTIPATION USING ORAL COMPOSITIONS OF METHYLNALTREXONE | Salix Pharmaceuticals, Ltd | Abandoned -- Failure to Respond to an Office Action | US20130317050A1 | Enoch BORTEY | United States | DRAPER, LESLIE A ROYDS |